Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoire Bailly-Creat is a French pharmaceutical company and Contract Development and Manufacturing Organization (CDMO) that specializes in the development, production, and distribution of oral solid and liquid medications. Established through the merger of Laboratoires Bailly and Laboratoires Creat, the company is a subsidiary of Groupe Vernin and maintains a high-capacity manufacturing site in Vernouillet, France. The facility is EU-GMP certified and handles a wide range of activities from formulation to industrial-scale production and primary/secondary packaging. Bailly-Creat serves both as a manufacturer of its own branded generic portfolio and as a strategic partner for major international pharmaceutical groups. Its commercial footprint is particularly strong in export markets, including over 30 countries across Africa, the Middle East, and French overseas territories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoire Bailly-Creat.